Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Many growth factors and cytokines are involved in liver regeneration. Of them, only
hepatopoietin
(
HPO
)/ALR (augmenter of liver regeneration) is a specifically hepatotrophic factor originally identified from the cytosol of regenerating or hyperplastic hepatic cells. Previous reports indicate that extracellular
HPO
triggers the MAPK pathway by binding its specific receptor on the cell surface. However, its function in the cytosol of hepatocytes is unclear. Here we identified that JAB1 (Jun activation domain-binding protein 1), a co-activator of AP-1, which is essential for liver regeneration, specifically interacts with intracellular
HPO
. JAB1 colocalizes with
HPO
in nuclei of hepatic cells or COS-7 cells. As an intracrine factor, the intracellular function of
HPO
is to increase
c-Jun
phosphorylation independent of
c-Jun
amino-terminal kinase (JNK), extracellular signal-regulated kinase (ERK) -1 and -2, and leads to potentiation of JAB1-mediated AP-1 activation. Amino acids 1-63 of
HPO
molecule are sufficient to bind to JAB1, but the full-length
HPO
is necessary for its intracellular signaling. Taken together, these results elucidate a novel mechanism of intracrine cytokine signaling by specifically modulating the AP-1 pathway through JAB1, in a MAPK-independent fashion.
...
PMID:Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway. 1170 97
It has been demonstrated that growth factors quiescin Q6 family was created by the fusion of the sulfhydryl oxidase fragment of the yeast essential for respiration and vegetative growth (ERV)1 prototype [an orthologue of
hepatopoietin
(
HPO
)] and thioredoxin (TRX)/disulfide isomerase domain during evolution. In this paper, our results demonstrated that two components of this composite protein, i.e.,
HPO
and TRX, were involved in the same signal transduction and interacted physically in eukaryocyte. When
HPO
and TRX were cotransfected into COS7 cells, the activity of activator protein-1 (AP-1) and NF-kappaB was evidently enhanced compared with the transfection with
HPO
or TRX alone, at the same time, the phosphorylation of
c-Jun
was increased. They were colocalized in the cells. By Co-IP and GST pull-down experiments, we found that
HPO
could physically interact with TRX, which was also confirmed by yeast two-hybrid assay. By further investigation, we found both
HPO
and TRX were sensitive to cellular oxidative state.
HPO
dimer is in its natural state and could be reduced by dithiothreitol (DTT) in vitro and in vivo. Under the treatment of oxidants such as H(2)O(2) and diamide, the amount of
HPO
monomer was decreased significantly and assembled into dimer, and the free thiol in TRX was oxidized.
HPO
could transfer oxidizing equivalents to TRX via direct thiol-disulfide exchange in vitro, the redox state of TRX was also affected by
HPO
in vivo. Taken together, it was implicated that the oxidizing equivalents might flow from
HPO
to TRX and then to substrate protein by the dimerization of
HPO
, and its interaction with TRX finally activates the redox-sensitive transcription factor, suggesting a new redox signal pathway conducted by thiol-disulfide transformation in eukaryocytic cytoplasm.
...
PMID:Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB. 1589 71